Sign In
Buy CDNA
$22.31
+0.240 (+1.09%)
At Close: Jun 03, 2026
CareDx to Report First Quarter 2020 Financial Results
11:00am, Tuesday, 21'st Apr 2020
SOUTH SAN FRANCISCO, Calif., April 21, 2020 -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of.
CareDx Inc (NASDAQ:CDNA) Shares Sold by Geode Capital Management LLC
10:26am, Monday, 20'th Apr 2020
Geode Capital Management LLC lowered its stake in CareDx Inc (NASDAQ:CDNA) by 1.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Co
Conestoga Capital Advisors LLC Has $574,000 Stock Holdings in CareDx Inc (NASDAQ:CDNA)
09:48am, Sunday, 19'th Apr 2020
Conestoga Capital Advisors LLC decreased its position in CareDx Inc (NASDAQ:CDNA) by 21.3% in the 1st quarter, HoldingsChannel reports. The fund owned 26,305 shares of the company’s stock after sell
Analysts Offer Insights on Healthcare Companies: Bioxcel Therapeutics (BTAI), Madrigal Pharmaceuticals (MDGL) and CareDx (CDNA)
11:22am, Wednesday, 15'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioxcel Therapeutics (BTAI), Madrigal Pharmaceuticals
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioxcel Therapeutics
Bank of New York Mellon Corp Boosts Position in CareDx Inc (NASDAQ:CDNA)
09:44am, Wednesday, 15'th Apr 2020
Bank of New York Mellon Corp boosted its holdings in CareDx Inc (NASDAQ:CDNA) by 0.6% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 262,783 shares of the company’
CareDx Introduces AlloCell: Cell Therapy Surveillance
11:00am, Tuesday, 14'th Apr 2020
AlloCell is a surveillance solution for patients who have received engineered-cell transplants for allogeneic cell therapy. Allogeneic cell therapy is a rapidly growing area of clinical development w
CareDx Inc (NASDAQ:CDNA) Shares Sold by UBS Asset Management Americas Inc.
10:16am, Monday, 13'th Apr 2020
UBS Asset Management Americas Inc. cut its holdings in CareDx Inc (NASDAQ:CDNA) by 12.0% in the 4th quarter, according to its most recent 13F filing with the SEC. The fund owned 29,770 shares of the c
Nuveen Asset Management LLC Decreases Stock Position in CareDx Inc (NASDAQ:CDNA)
09:40am, Monday, 13'th Apr 2020
Nuveen Asset Management LLC lessened its stake in CareDx Inc (NASDAQ:CDNA) by 7.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commissi
Craig Hallum Cuts CareDx (NASDAQ:CDNA) Price Target to $42.00
10:18am, Sunday, 12'th Apr 2020
CareDx (NASDAQ:CDNA) had its price target decreased by Craig Hallum from $48.00 to $42.00 in a report published on Thursday, The Fly reports. Craig Hallum currently has a buy rating on the stock. Seve
Is CareDx, Inc’s (NASDAQ:CDNA) CEO Paid Enough Relative To Peers?
12:44pm, Saturday, 11'th Apr 2020
In 2012 Peter Maag was appointed CEO of CareDx, Inc (NASDAQ:CDNA). This report will, first, examine the CEO...
Biohaven on go with study of vazegepant in COVID-19 as others take action amid the pandemic
12:04pm, Thursday, 09'th Apr 2020
The FDA has signed off on a Phase 2 clinical trial evaluating intranasal administration of Biohaven Pharmaceutical Holding Company's (NYSE:BHVN) migraine med vazegepant, a calcitonin gene-related pept
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs April 8)
Keros Therapeutics Inc (...
